Back

Impact of vaccination in reducing Hospital expenses, Mortality and Average length of stay among COVID 19 patients. A retrospective cohort study from India

Ramakrishnan, M.; Subbarayan, P.

2021-06-22 infectious diseases
10.1101/2021.06.18.21258798 medRxiv
Show abstract

Background & AimWHO listed vaccine hesitancy among the top 10 global threats to health and there are very few reports highlighting vaccine benefits against COVID-19. The aim of this study was to study the impact of vaccination on reducing the average length of stay (ALOS), intensive care unit (ICU) requirement, mortality and cost of the treatment among COVID-19 patients. MethodsIn this retrospective cohort study all the patients above 45 years who underwent treatment for COVID-19 were included. The data of patients treated pan India during the period March & April 2021 with the diagnosis of COVID-19, under health insurance cover, were extracted to study parameters like the ALOS, mortality, ICU requirement, total hospital expenses incurred and the vaccination status. ResultsAmong 3820 patients with COVID-19, 3301 (86.4%) were unvaccinated while 519 (13.6%) were vaccinated. Among the unvaccinated the mean (s.d) ALOS was 7 days. Fourteen days after second dose of vaccination this was significantly less (p=0.01) at 4.9. The mean total hospital expense among the unvaccinated was Rs. 277850. Fourteen days after second dose of vaccination this was further less (p=0.001) at Rs. 217850. Among the unvaccinated population 291/3301 (8.8%) required ICU and this was significantly less (p=0.03) at 31/519 (6%) among the vaccinated. Among those who received two doses of vaccination it was further less at 1/33 (3%). The mortality among unvaccinated patients was 16/3301 (0.5%) while there was no mortality among the vaccinated. Among those who received two doses of vaccination there was a 66% relative risk reduction in ICU stay and 81% relative risk reduction in mortality. ConclusionsThere was a significant reduction in ALOS, ICU requirement, mortality & treatment cost in patients who had completed two doses of vaccination. These findings may be used in motivating public and promoting vaccination drive.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 10%
18.1%
2
Cureus
67 papers in training set
Top 0.8%
4.8%
3
IJID Regions
10 papers in training set
Top 0.1%
4.3%
4
BMJ Open
554 papers in training set
Top 5%
3.9%
5
BMC Infectious Diseases
118 papers in training set
Top 1%
3.6%
6
International Journal of Infectious Diseases
126 papers in training set
Top 0.6%
3.6%
7
Frontiers in Public Health
140 papers in training set
Top 2%
3.6%
8
PLOS Global Public Health
293 papers in training set
Top 2%
3.6%
9
Scientific Reports
3102 papers in training set
Top 37%
3.6%
10
BMC Public Health
147 papers in training set
Top 2%
3.0%
50% of probability mass above
11
Journal of Family Medicine and Primary Care
10 papers in training set
Top 0.1%
3.0%
12
Vaccines
196 papers in training set
Top 0.8%
2.9%
13
Epidemiology and Infection
84 papers in training set
Top 0.8%
2.6%
14
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.3%
2.1%
15
Public Health
34 papers in training set
Top 0.4%
1.9%
16
Frontiers in Medicine
113 papers in training set
Top 3%
1.9%
17
F1000Research
79 papers in training set
Top 1%
1.9%
18
Journal of Medical Virology
137 papers in training set
Top 2%
1.7%
19
Vaccine
189 papers in training set
Top 1%
1.7%
20
PeerJ
261 papers in training set
Top 7%
1.7%
21
Healthcare
16 papers in training set
Top 0.9%
1.3%
22
eClinicalMedicine
55 papers in training set
Top 1%
0.9%
23
JMIR Public Health and Surveillance
45 papers in training set
Top 3%
0.9%
24
COVID
13 papers in training set
Top 0.3%
0.8%
25
Vaccine: X
19 papers in training set
Top 0.3%
0.8%
26
PLOS Neglected Tropical Diseases
378 papers in training set
Top 5%
0.7%
27
Archives of Clinical and Biomedical Research
28 papers in training set
Top 2%
0.7%
28
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 4%
0.7%
29
JMIRx Med
31 papers in training set
Top 2%
0.7%
30
Clinical Infectious Diseases
231 papers in training set
Top 5%
0.6%